Pan Birmingham Gynaecological Cancer Centre, City Hospital, Birmingham, UK.
J Low Genit Tract Dis. 2011 Apr;15(2):89-92. doi: 10.1097/LGT.0b013e3181f1ab95.
To investigate the indications for performing a second large loop excision of the transformation zone (LLETZ) biopsy and to compare the associated colposcopic and pathological findings and treatment morbidity compared with 1 LLETZ.
This is a case-control study that reviewed case notes and histology reports on women who had undergone 1 LLETZ biopsy (control group) and women who had undergone 2 biopsies (index group). A comparison of referral cytology, colposcopic findings, and pathological and clinical outcomes was performed.
Of the women who went on to have 2 LLETZ biopsies, 88% had histologically proven high-grade cervical intraepithelial neoplasia (CIN) or invasion on their first biopsy. A significantly greater proportion of high-grade cytologic and histologic diagnoses were associated with the first LLETZ compared with the second LLETZ biopsy, 76.5% and 69.1% versus 39.5% and 30.9%, respectively. A significantly greater proportion of women in the control group were referred with low-grade cytology (28.0%) and were diagnosed with human papillomavirus/low-grade CIN on histology (31.7%) compared with the first cytologic and LLETZ results in the index group, 9.9% and 8.6%, respectively. Complications were low in both groups; the immediate complication rate was 4% after the first LLETZ compared with 1% after the second LLETZ.
Most second LLETZ biopsies are performed in women with a history of biopsy-proven high-grade CIN and are not associated with an increased risk of immediate complications.
本研究旨在探讨行第二次大环形电切术(LLETZ)活检的适应证,并与单次 LLETZ 活检相比,比较其阴道镜和病理检查结果以及治疗相关发病率。
本病例对照研究回顾性分析了行单次 LLETZ 活检(对照组)和行 2 次活检(观察组)的女性患者的病历和组织学报告。比较转诊细胞学、阴道镜表现以及病理学和临床结局。
在接受 2 次 LLETZ 活检的女性中,88%的患者在首次活检时组织学证实为高级别宫颈上皮内瘤变(CIN)或浸润。与第二次 LLETZ 活检相比,第一次 LLETZ 活检时与高级别细胞学和组织学诊断相关的比例显著更高,分别为 76.5%和 69.1%,而第二次 LLETZ 活检时的比例分别为 39.5%和 30.9%。与观察组首次细胞学和 LLETZ 结果相比,对照组中更多的女性转诊时有低级别细胞学结果(28.0%)和组织学诊断为人乳头瘤病毒/低级别 CIN(31.7%)。
大多数第二次 LLETZ 活检是在有活检证实的高级别 CIN 病史的女性中进行的,与即刻并发症风险增加无关。